home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

3rd Annual Vaccines Congress 2013

 
  February 04, 2013  
     
 
Oxford Global Conferences, London
25th&26th March 2013


The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 20 speakers will present a full conference programme covering the topics outlined below.

Day 1 – Vaccine Discovery and Development

  • Prophylactic Vaccines
  • Therapeutic Vaccines
  • DNA and RNA Based Approaches
  • Novel Development Strategies
  • Tropical Diseases
  • Technological Advances

Day 2 – Clinical Development and Clinical trials

  • Clinical Trial Programs
  • Adjuvant Technologies
  • Regulatory Updates
  • Trials in Emerging Markets
  • New Administration Methods
  • Vector Vaccines
 
 
Organized by: Oxford Global Conferences
Invited Speakers:
  • Nathaly Arndtz-Wiedemann
    Vice President Medical Affairs, Bavarian Nordic GmbH
  • Jochen Auerbach
    Head Regulatory Affairs, Novartis Vaccines Institute for Global Health (NVGH)
  • Matthew Bottomley
    Head of Structural Biology Unit, Novartis
  • Miles Caroll
    Head of Research, HPA
  • Brian Champion
    Executive Director, Pfizer
  • Jim Eyles
    Associate Research Fellow, Pfizer
  • Antonella Folgori,
    Director, Okairos
  • Aurelia Haller,
    Director, Vaccine Development & Regulatory Affairs, Inviragen Inc
  • Jon Heinrichs,
    Director, Merck
  • Julianna Lisziewicz
    Genetic Immunity
  • Peter Mason
    Head Microbial Molecular Biology, Novartis
  • David McIntosh,
    Global Scientific Affairs Senior Expert, Novartis Vaccines and Diagnosis
  • Martina Ochs
    Director, Sanofi Pasteur
  • Derek O’Hagan
    Global Head of Vaccine Delivery and Formulation Research, Novartis
  • Elliot Parks,
    President and CEO, Hawaii Biotech Inc
  • Léonie Paterson,
    Regulatory Product Manager, Sanofi Pasteur
  • Eric Plennevaux,
    Clinical Director, Sanofi Pasteur
  • Tatjana Plješa
    Production Director, Institute of Virology, Vaccines and Sera Torlak
  • Charles Richardson
    Vice President, Ligocyte
  • Ulla Seppälä
    Discovery Licensing Manager, ALK-Abelló
  • Derek Smith
    Professor, University of Cambridge
  • Linda Starr-Spires
    Director, Sanofi Pasteur
  • Geraldine Taylor
    Principal Investigator, The Pirbright Institute
  • Lynda Tussey,
    VP Development, VaxInnate
 
Deadline for Abstracts: Filled
 
Registration: For more information and to register: http://www.vaccines-congress.com/download-agenda/
E-mail: d.meredith@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.